Skip to main content
. 2014 May 19;33(1):43. doi: 10.1186/1756-9966-33-43

Table 4.

Indications and contraindications of TAE in patients with NENs

Indications Contraindications
- NEN tumor functioning or not
- Massive tumor burden
- Highly vascularised liver metastases
- Severely compromised liver function
- Liver metastases >3 in number and or >3 cm in size
- Poor performance status
- Sepsis
- Patients with tumor mass-related symptoms and/or carcinoid syndrome - Carcinoid heart disease and other risk factors for treatment related mortality